BridgeMD
New treatment option for Asthma in Children
Official title The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception
ClinicalTrials.gov ID: NCT06702735
What this study is testing
- What it's testing
- Asthma is a common childhood disease that is characterized by chronic airway inflammation and episodic expiratory airflow obstruction. Asthma symptoms can impair participation in play and sports and have a negative impact on quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 15
You may be able to join if
- Selection phase:
- Pediatrician diagnosed asthma
- Health care professional thinks perception might be poor
- Age 7 until 15 years old
- Adequate understanding of Dutch language Intervention phase:
You likely can't join if
- Severe comorbidity (for example psychomotor retardation or severe cardiopulmonary conditions)
- Not able to fill in VAS score (for example due to blindness)
- Not able to perform technically correct spirometry manoeuvres
- Medication change in past 2 weeks
- Exacerbation which required oral prednisone in the past 6 weeks
- Exacerbation at the moment of inclusion
See the full eligibility criteria
- Selection phase:
- Pediatrician diagnosed asthma
- Health care professional thinks perception might be poor
- Age 7 until 15 years old
- Adequate understanding of Dutch language Intervention phase:
- Adequate number of lung function measurements + VAS scores during selection phase, defined as:
- At least 4 measurements after exercise or when experiencing symptoms and
- At least 2 standard measurements
- Poor perception during selection phase, defined as:
- At least 1 measurement in red zone on Perception Rainbow and/or
- At least 2 measurements in orange zone on Perception Rainbow and/or
- Average of all measurements after exercise or when experiencing symptoms in yellow zone (or orange/red)and/or
- Average of all measurements in yellow zone (or orange/red)
- Severe comorbidity (for example psychomotor retardation or severe cardiopulmonary conditions)
- Not able to fill in VAS score (for example due to blindness)
- Not able to perform technically correct spirometry manoeuvres
- Medication change in past 2 weeks
- Exacerbation which required oral prednisone in the past 6 weeks
- Exacerbation at the moment of inclusion
- No device (computer, tablet or smartphone) with internet connection available at home
The study team makes the final eligibility decision.
Where it's taking place
- Enschede, Overijssel, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 15 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Enschede, Overijssel, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.